Wellnex Life is the lead ASX “runner of the week” after its shares rise following an agreement to sell its Pain Away medicinal cream brand for up to $21.3 million. Multiple outlets report that the transaction is structured as a sale with potential value up to that figure, and that the company expects the proceeds to remove its debt. The coverage across newspapers highlights the same core development: the company’s announcement of the Pain Away brand sale and the market reaction that follows. Each source links the share movement to the prospect of becoming debt-free as a result of the deal. While the articles focus on Wellnex Life as the featured stock for the week, they do not provide additional, differing details in the supplied excerpts about the buyer, timing of completion, or specific conditions beyond the stated maximum sale price and the debt reduction outcome. Overall, the agreement to sell the Pain Away brand for up to $21.3 million is presented as the key catalyst behind the company’s stock performance.
Wellnex shares surge after deal to sell Pain Away brand for up to $21.3 million
Wellnex Life is the lead ASX “runner of the week” after its shares rise following an agreement to sell its Pain Away medicinal cream brand for up to $21.3 million. Multiple outlets report that the tra...
- Wellnex Life’s shares rise and it is named an ASX runner of the week by multiple outlets.
- The company agrees to sell its Pain Away medicinal cream brand.
- The deal is reported as worth up to $21.3 million.
- The transaction is expected to make Wellnex debt-free.
- The reported share reaction is attributed to the announced brand sale agreement.
The Bulls N’ Bears ASX Runner of the Week is… Wellnex Life, which rocketed after agreeing to sell its Pain Away medicinal cream brand for up to $21.3 million, a deal that will see it become debt-free.
2 months agoThe Bulls N’ Bears ASX Runner of the Week is… Wellnex Life, which rocketed after agreeing to sell its Pain Away medicinal cream brand for up to $21.3 million, a deal that will see it become debt-free.
2 months agoThe Bulls N’ Bears ASX Runner of the Week is… Wellnex Life, which rocketed after agreeing to sell its Pain Away medicinal cream brand for up to $21.3 million, a deal that will see it become debt-free.
2 months agoThe Bulls N’ Bears ASX Runner of the Week is… Wellnex Life, which rocketed after agreeing to sell its Pain Away medicinal cream brand for up to $21.3 million, a deal that will see it become debt-free.
2 months ago
McKinsey removes partner from leadership role after LinkedIn posts on women’s workplace challenges
McKinsey removes an Australian partner from a leadership role within the firm’s research arm after an internal review of...
IonQ to acquire Elisity for up to $1.3 billion in all-stock deal
IonQ Inc. has agreed to buy cybersecurity firm Elisity Inc. for up to $1.3 billion, using an all-stock transaction, acco...
LTTS launches AI-Native Factory and targets 80% revenue from strategic AI focus areas
LTTS says it is making artificial intelligence a major growth focus, launching an AI-Native Factory lab in Bengaluru and...